ATE554389T1 - Apex als marker für lungenkrebs - Google Patents

Apex als marker für lungenkrebs

Info

Publication number
ATE554389T1
ATE554389T1 AT08716640T AT08716640T ATE554389T1 AT E554389 T1 ATE554389 T1 AT E554389T1 AT 08716640 T AT08716640 T AT 08716640T AT 08716640 T AT08716640 T AT 08716640T AT E554389 T1 ATE554389 T1 AT E554389T1
Authority
AT
Austria
Prior art keywords
lung cancer
apex
marker
assessment
relates
Prior art date
Application number
AT08716640T
Other languages
English (en)
Inventor
Marie-Luise Hagmann
Johann Karl
Julia Kloeckner
Markus Roessler
Michael Tacke
Michael Thierolf
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE554389T1 publication Critical patent/ATE554389T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08716640T 2007-03-23 2008-03-19 Apex als marker für lungenkrebs ATE554389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07006079 2007-03-23
PCT/EP2008/002224 WO2008116592A1 (en) 2007-03-23 2008-03-19 Apex as a marker for lung cancer

Publications (1)

Publication Number Publication Date
ATE554389T1 true ATE554389T1 (de) 2012-05-15

Family

ID=38480598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08716640T ATE554389T1 (de) 2007-03-23 2008-03-19 Apex als marker für lungenkrebs

Country Status (8)

Country Link
US (1) US20110097756A1 (de)
EP (1) EP2130048B1 (de)
JP (1) JP5079023B2 (de)
CN (1) CN101641599A (de)
AT (1) ATE554389T1 (de)
CA (1) CA2681577A1 (de)
ES (1) ES2384125T3 (de)
WO (1) WO2008116592A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5690039B2 (ja) 2004-06-04 2015-03-25 バイオセラノスティクス インコーポレイテッドＢｉｏｔｈｅｒａｎｏｓｔｉｃｓ，Ｉｎｃ． 腫瘍の同定
US20120258442A1 (en) 2011-04-09 2012-10-11 bio Theranostics, Inc. Determining tumor origin
CN101297045A (zh) 2005-06-03 2008-10-29 阿威亚拉德克斯股份有限公司 肿瘤和组织的鉴定
ES2439966T3 (es) * 2008-11-12 2014-01-27 F. Hoffmann-La Roche Ag PACAP como marcador para el cáncer
ES2493069T3 (es) * 2009-05-15 2014-09-11 F. Hoffmann-La Roche Ag CYBP como marcador del cáncer de pulmón
WO2010136163A1 (en) * 2009-05-29 2010-12-02 Roche Diagnostics Gmbh Secernin-1 as a marker for cancer
CN101930004A (zh) * 2009-06-24 2010-12-29 中国科学院上海生命科学研究院 Apex1用作检测肝细胞癌的蛋白质分子标记的应用
KR101251222B1 (ko) * 2010-12-08 2013-04-08 충남대학교산학협력단 ＡＰＥ1/Ｒｅｆ-1을 함유하는 방광암 진단용 조성물, 및 이를 이용한 방광암 진단 키트
CA2826811A1 (en) * 2011-03-11 2012-09-20 F. Hoffmann-La Roche Ag Apex1 as marker for chronic obstructive pulmonary disease (copd)
CN102435748B (zh) * 2011-11-25 2014-07-16 广东药学院 一种双抗夹心酶联免疫检测试剂盒及其制备方法
CN102507951B (zh) * 2011-11-25 2014-11-19 广东药学院 一种联合检测肿瘤标志物的酶联免疫检测试剂盒
MX361092B (es) * 2013-05-23 2018-11-26 Iphenotype Llc Base de datos de búsqueda social integrada fenotípica y método.
CN105891482B (zh) * 2016-03-29 2017-12-19 复旦大学附属中山医院 一种基于生物标志物谱针对中国农村人口肺结节人群的肺癌风险预测模型
CN106018807A (zh) * 2016-05-11 2016-10-12 卢氏实验室公司 一种快速诊断和监控肺癌的免疫层析检测条及其制备方法
CN106053816B (zh) * 2016-08-19 2018-01-05 四川大学华西第二医院 肺癌诊断试剂盒
CN106645722B (zh) * 2016-10-17 2018-09-04 四川大学华西第二医院 一种肺癌筛查试剂盒
CN107860852A (zh) * 2017-11-23 2018-03-30 南宁科城汇信息科技有限公司 一种基于iTRAQ联合LC、MALDI的差异蛋白组学

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0923738A1 (de) * 1996-06-11 1999-06-23 Advanced Research & Technology Institute Verfahren und zubereitungen für die verwendung von apurinischen/apyrimidinischen endonukleasen
EP1140194A2 (de) * 1998-12-23 2001-10-10 G.D. SEARLE & CO. Verwendung von einen cyclooxygenase-2 inhibitor, einen matrix metalloproteinase-inhibitor, einen antineoplastische wirkstoff und wahlweise bestrahlung als kombinationsterapie von neoplasie
US20030003454A1 (en) * 2001-03-23 2003-01-02 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
US8043807B2 (en) * 2001-03-23 2011-10-25 Yeda Research And Development Co. Ltd. Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
JP3691798B2 (ja) * 2002-02-18 2005-09-07 三洋化成工業株式会社 血液中の腫瘍マーカー定量方法
WO2004063355A2 (en) * 2003-01-10 2004-07-29 Protein Design Labs, Inc. Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
US20080138797A1 (en) * 2003-11-13 2008-06-12 Hunt William D Detection Systems and Methods
US7611845B2 (en) * 2004-12-17 2009-11-03 Siemens Healthcare Diagnostics Inc. Serum levels of HER2/neu as an indicator of clinical state and prognosis of prostate cancer
JP5150909B2 (ja) * 2005-07-27 2013-02-27 オンコセラピー・サイエンス株式会社 食道癌を診断する方法
WO2008036465A2 (en) * 2006-09-18 2008-03-27 CMED Technologies Ltd. Office of Walkers Limited A method to assess cancer susceptibility and differential diagnosis of metastases of unknown primary tumors
AU2008226587A1 (en) * 2007-03-09 2008-09-18 Tripath Imaging, Inc. HE4 monoclonal antibodies and methods for their use

Also Published As

Publication number Publication date
CN101641599A (zh) 2010-02-03
JP2010521688A (ja) 2010-06-24
WO2008116592A1 (en) 2008-10-02
EP2130048A1 (de) 2009-12-09
US20110097756A1 (en) 2011-04-28
CA2681577A1 (en) 2008-10-02
JP5079023B2 (ja) 2012-11-21
EP2130048B1 (de) 2012-04-18
ES2384125T3 (es) 2012-06-29

Similar Documents

Publication Publication Date Title
ATE554389T1 (de) Apex als marker für lungenkrebs
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
PH12018550037A1 (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX2015016047A (es) Metodo y sistema para mantener o mejorar el bienestar.
WO2014020502A3 (en) Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
BR112015019567A2 (pt) marcadores associados com inibidores de wnt
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
MX2012007009A (es) Método para diagnosticar un tumor maligno.
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
WO2010000467A8 (en) Asc as a marker for lung cancer
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
EP2554993A4 (de) Marker zur diagnose der wirkung eines antikrebsmittels
ATE531822T1 (de) Diagnose von prostatakrebs
MX2012000041A (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
WO2010130839A4 (en) Cybp as a marker of lung cancer
WO2013165969A3 (en) Methods and kits for diagnosing heparin-induced thrombocytopenia